Responsiveness of NEI VFQ-25 to Changes in Visual Acuity in Neovascular AMD: Validation Studies from Two Phase 3 Clinical Trials
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
PURPOSE: To examine the responsiveness of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) by using data from the MARINA and ANCHOR trials in neovascular age-related macular degeneration (AMD) and to establish the change in the NEI VFQ-25 associated with a 15-letter change in best corrected visual acuity (BCVA). METHODS: In MARINA, 716 patients were randomized to monthly intravitreal ranibizumab (0.3 or 0.5 mg) or sham injections. In ANCHOR, 423 patients were randomized to monthly ranibizumab (0.3 or 0.5 mg) with sham photodynamic therapy (PDT) or sham ocular injections with verteporfin PDT. Patients had follow-up interviews and BCVA measurements over 24 months. Data were analyzed separately for MARINA and ANCHOR, and treatment groups were pooled within each trial. The clinically relevant difference in NEI VFQ-25 was estimated based on regression models of change from baseline to month 12 in BCVA. RESULTS: Subgroups categorized by BCVA change (>or=15 letters gained, <15 letters lost or gained, or >or=15 letters lost) differed substantially in mean change in NEI VFQ-25 composite scores and three pre-specified subscale scores (near activities, distance activities, and vision-specific dependency) over 12 months. According to the regression models, the difference associated with a 15-letter change was 4 to 6 points for the composite score and the three pre-specified subscales. CONCLUSIONS: These data support the use of the NEI VFQ-25 as a responsive and sensitive measure of vision-related function in neovascular AMD populations. Based on MARINA and ANCHOR data, a 4- to 6-point change in NEI VFQ-25 scores represents a clinically meaningful change corresponding to a 15-letter change in BCVA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“At week 96, the score increase from baseline was clinically relevant in the following subscales: mental health (þ15.8points), dependency (þ7.8 points), and role difficulties (þ7.7 points).25”
From Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset (2021) · cites this paper as [25]
Citations
Cites
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522 · cited 5×
“measured at 2 m at each visit and at 4 m at day 0, month 12, and month 24.(24) NEI VFQ-25 Methods”
BackgroundResultInfluentialPrevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Development of the 25-list-item National Eye Institute Visual Function Questionnaire
Mangione, C. M. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.7.1050 · Cited by 2,230
Measuring change over time: Assessing the usefulness of evaluative instruments
Guyatt, G., Walter, S., & Norman, G. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90069-5 · Cited by 1,880
Prevalence of Open-Angle Glaucoma Among Adults in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.532 · Cited by 1,110
Klaver, C. C. W. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.5.653 · Cited by 881
Psychometric Properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ)
Mangione, C. M. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.11.1496 · Cited by 848
Age-related macular degeneration
de Jong, P. T. V. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062326 · Cited by 787
Cited by
Mitchell, P., Bandello, F., Schmidt-Erfurth, U., Lang, G. E., Massin, P., Schlingemann, R. O., Sutter, F., Simader, C., Burian, G., Gerstner, O., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.031 · Cited by 1,326
Wall, M., McDermott, M. P., Kieburtz, K. D., Corbett, J. J., Feldon, S. E., Friedman, D. I., Katz, D. M., Keltner, J. L., Schron, E. B., & Kupersmith, M. J. (2014) · JAMA · doi:10.1001/jama.2014.3312 · Cited by 550
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
Solomon, S. D., Lindsley, K., Vedula, S. S., Krzystolik, M. G., & Hawkins, B. S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005139.pub3 · Cited by 520
Kempen, J. H., Altaweel, M. M., Holbrook, J. T., Jabs, D. A., Louis, T. A., Sugar, E. A., & Thorne, J. E. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.07.027 · Cited by 334
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
Solomon, S. D., Lindsley, K., Vedula, S. S., Krzystolik, M. G., & Hawkins, B. S. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005139.pub4 · Cited by 271
Yu-Wai-Man, P., Newman, N. J., Carelli, V., Moster, M. L., Biousse, V., Sadun, A. A., Klopstock, T., Vignal-Clermont, C., Sergott, R. C., Rudolph, G., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz7423 · Cited by 232
Cook, J., Hislop, J., Adewuyi, T., Harrild, K., Altman, D., Ramsay, C., Fraser, C., Buckley, B., Fayers, P., Harvey, I., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18280 · Cited by 194
Anti-vascular endothelial growth factor therapy for diabetic macular edema
Boyer, D. S., Hopkins, J. J., Sorof, J., & Ehrlich, J. S. (2013) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018813512360 · Cited by 193
Newman, N. J., Yu-Wai-Man, P., Carelli, V., Moster, M. L., Biousse, V., Vignal-Clermont, C., Sergott, R. C., Klopstock, T., Sadun, A. A., Barboni, P., et al. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2020.12.012 · Cited by 168
“Clinically relevant change was determined as described previously.(25)”
BackgroundMethodChronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life
Breukink, M. B., Dingemans, A. J., den Hollander, A. I., Keunen, J. E., MacLaren, R. E., Fauser, S., Querques, G., Hoyng, C. B., Downes, S. M., & Boon, C. J. (2016) · Clinical Ophthalmology · doi:10.2147/opth.s115685 · Cited by 158
Writing Committee for the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group, Kempen, J. H., Altaweel, M. M., Holbrook, J. T., Sugar, E. A., Thorne, J. E., & Jabs, D. A. (2017) · JAMA · doi:10.1001/jama.2017.5103 · Cited by 129
Rapid and Reliable Assessment of the Contrast Sensitivity Function on an iPad
Dörr, M., Lesmes, L. A., Lu, Z., & Bex, P. J. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-11743 · Cited by 121
Mackensen, F., Jakob, E., Springer, C., Dobner, B. C., Wiehler, U., Weimer, P., Rohrschneider, K., Fiehn, C., Max, R., Storch-Hagenlocher, B., et al. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.05.002 · Cited by 102
“The patient is speaking”: discovering the patient voice in ophthalmology
Dean, S., Mathers, J. M., Calvert, M., Kyte, D. G., Conroy, D. M., Folkard, A., Southworth, S., Murray, P. I., & Denniston, A. K. (2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-309955 · Cited by 109
Don’t middle your MIDs: regression to the mean shrinks estimates of minimally important differences
Fayers, P. M., & Hays, R. D. (2014) · Quality of Life Research · doi:10.1007/s11136-013-0443-4 · Cited by 95
Thach, A. B., Yau, L., Hoang, C., & Tuomi, L. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.11.022 · Cited by 98
Yuzawa, M., Fujita, Tanaka, E., & Wang (2013) · Clinical ophthalmology · doi:10.2147/opth.s45248 · Cited by 85
Sheppard, J. D., Joshi, A. D., Betts, K. A., Hudgens, S. A., Tari, S. R., Chen, N., Skup, M., & Dick, A. D. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.0603 · Cited by 80
Schmucker, C. M., Loke, Y. K., Ehlken, C., Agostini, H. T., Hansen, L. L., Antes, G., & Lelgemann, M. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.178574 · Cited by 87
Frick, K. D., Drye, L. T., Kempen, J. H., Dunn, J. P., Holland, G. N., Latkany, P. A., Rao, N. A., Sen, H. N., Sugar, E. A., Thorne, J. E., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8259 · Cited by 75
The impact of a better-seeing eye and a worse-seeing eye on vision-related quality of life
Hirneiß, C. (2014) · Clinical ophthalmology · doi:10.2147/opth.s64200 · Cited by 79
Sung, Y., Lee, M. J., Choi, J., Jung, S. Y., Chong, S. Y., Sung, J. H., Shim, S. H., & Song, W. K. (2021) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-316225 · Cited by 66
Biousse, V., Newman, N. J., Yu-Wai-Man, P., Carelli, V., Moster, M. L., Vignal-Clermont, C., Klopstock, T., Sadun, A. A., Sergott, R. C., Hage, R., et al. (2021) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000001367 · Cited by 78
Gonder, J. R., Walker, V. M., Barbeau, M., Zaour, N., Zachau, B. H., Hartje, J. R., & Li, R. (2014) · Journal of Ophthalmology · doi:10.1155/2014/939315 · Cited by 73
Abraham, I., Rakic, Leys, A., Brie, Denhaerynck, Pacheco, Vancayzeele, Hermans, & MacDonald, K. (2013) · Clinical Ophthalmology · doi:10.2147/opth.s49385 · Cited by 72
Varma, R., Richman, E. A., Ferris, F. L., & Bressler, N. M. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5627 · Cited by 67
Self-citationPatel, P. J., Ziemssen, F., Ng, E., Muthutantri, A., Silverman, D., Tschosik, E. A., & Cantrell, R. A. (2020) · Clinical Ophthalmology · doi:10.2147/opth.s226425 · Cited by 61
“America.2 GA has also been associated with more cases of legal blindness (severe sight loss/registered blind) in England and Wales than other forms of AMD.5 The incidence of GA increases exponentially with age, and as the population ages, the prevalence of the disease is expected to rise.4,6 GA comprises a spectrum of…”
BackgroundResultInfluentialDeterminants of Quality of Life in Geographic Atrophy Secondary to Age-Related Macular Degeneration
Künzel, S. H., Möller, P. T., Lindner, M., Goerdt, L., Nadal, J., Schmid, M. C., Schmitz-Valckenberg, S., Holz, F. G., Fleckenstein, M., & Pfau, M. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.5.63 · Cited by 58
Vision-Related Function after Ranibizumab Treatment for Diabetic Macular Edema
Bressler, N. M., Varma, R., Suñer, I. J., Dolan, C., Ward, J., Ehrlich, J. S., Colman, S. S., & Turpcu, A. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.07.008 · Cited by 60
Self-citationKing, A. J., Fernie, G., Azuara‐Blanco, A., Burr, J. M., Garway‐Heath, D. F., Sparrow, J. M., Vale, L. D., Hudson, J., MacLennan, G., McDonald, A. M., et al. (2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2017-310902 · Cited by 56
Sivaprasad, S., Tschosik, E., Kapre, A., Varma, R., Bressler, N. M., Kimel, M., Dolan, C., & Silverman, D. G. (2018) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2018.03.006 · Cited by 56
Self-citationAssessment of patient-reported outcomes in retinal diseases: a systematic review
Senthil, M. P., Khadka, J., & Pesudovs, K. (2017) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2016.12.011 · Cited by 58
Comparison of Scoring Approaches for the NEI VFQ‐25 in Low Vision
Dougherty, B. E., & Bullimore, M. A. (2010) · Optometry and Vision Science · doi:10.1097/opx.0b013e3181e61bd8 · Cited by 55
Mitchell, P. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.4592 · Cited by 48
Schmucker, C., Ehlken, C., Hansen, L. L., Antes, G., Agostini, H. T., & Lelgemann, M. (2010) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e3283386783 · Cited by 47
Beaulieu, W. T., Bressler, N. M., Melia, M., Owsley, C. J., Mein, C. E., Gross, J. G., Jampol, L. M., & Glassman, A. R. (2016) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2016.08.008 · Cited by 51
Self-citationSakai, T., Watanabe, H., Kuroyanagi, K., Akiyama, G., Okano, K., Kohno, H., & Tsuneoka, H. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-302515 · Cited by 47
Improvement in Vision-Related Function with Intravitreal Aflibercept
Yuzawa, M., Fujita, K., Wittrup-Jensen, K. U., Norenberg, C., Zeitz, O., Adachi, K., Wang, E. C. Y., Heier, J. S., Kaiser, P. K., Chong, V. N., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.09.024 · Cited by 51
Kowalski, J. W., Rentz, A. M., Walt, J. G., Lloyd, A. J., Lee, J., Young, T. A., Chen, W.-H., Bressler, N. M., Lee, P. P., Brazier, J. E., et al. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9938-z · Cited by 45
Self-citationComparison of Clinical Trial and Systematic Review Outcomes for the 4 Most Prevalent Eye Diseases
Saldanha, I. J., Lindsley, K. B., Diana, V., Chuck, R. S. H., MEYERLE, C. B., Jones, L. S., Coleman, A. L., JAMPEL, H. D., Dickersin, K., & Virgili, G. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2583 · Cited by 39
Loftus, J., Sultan, M. B., & Pleil, A. M. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7613 · Cited by 47
Petrillo, J., Bressler, N. M., Lamoureux, E. L., Ferreira, A., & Cano, S. (2017) · Health and Quality of Life Outcomes · doi:10.1186/s12955-017-0726-5 · Cited by 42
Self-citationSheth, J. U., Stewart, M. W., Narayanan, R., Anantharaman, G., Chandran, K., Lai, T. Y. Y., Chakravarthy, U., & Das, T. (2024) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2024.08.003 · Cited by 43
Hislop, J., Adewuyi, T. E., Vale, L. D., Harrild, K., Fraser, C., Gurung, T., Altman, D. G., Briggs, A. H., Fayers, P., Ramsay, C. R., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001645 · Cited by 36
To, K. G., Meuleners, L. B., Fraser, M. L., Do, D. V., Duong, D., Huynh, V.-A. N., To, K. G., Phi, T. D., Tran, H. H., & Nguyen, N. D. (2014) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-12-16 · Cited by 38
Muni, R. H., Francisconi, C. L. M., Felfeli, T., Mak, M. Y. K., Berger, A. R., Wong, D. T., Altomare, F., Giavedoni, L. R., Kohly, R. P., Kertes, P. J., et al. (2020) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2020.2007 · Cited by 35
Heo, J. W., Yoon, H. S., Shin, J. P., Moon, S. W., Chin, H. S., & Kwak, H. W. (2010) · Journal of the Korean Ophthalmological Society · doi:10.3341/jkos.2010.51.10.1354 · Cited by 34
Wang, J., Zhang, J., Yu, S., Li, H., Chen, S., Luo, J., Wang, H., Guan, Y., Zhang, H., Yin, S., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01806-3 · Cited by 37
Cell-Based Ciliary Neurotrophic Factor Therapy for Macular Telangiectasia Type 2
Chew, E. Y., Gillies, M., Jaffe, G. J., Gaudric, A., Egan, C. A., Constable, I. J., Clemons, T. E., Aaberg, T. M., Manning, D. C., Hohman, T. C., et al. (2025) · NEJM Evidence · doi:10.1056/evidoa2400481 · Cited by 32
Five-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy
Yu‐Wai‐Man, P., Newman, N. J., Biousse, V., Carelli, V., Moster, M. L., Vignal‐Clermont, C., Klopstock, T., Sadun, A. A., Sergott, R. C., Hage, R., et al. (2024) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2024.5375 · Cited by 41
A synthetic opsin restores vision in patients with severe retinal degeneration
Mohanty, S. K., Mahapatra, S., Batabyal, S., Carlson, M. E., Kanungo, G., Ayyagari, A. L., Tchedre, K. T., Franco, J. A., Singer, M. A., Barone, S. B., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.031 · Cited by 43
Economic and Quality of Life Benefits of Anti-VEGF Therapy
Hodgson, N. M., Wu, F., Zhu, J., Wang, W., Ferreyra, H. A., Zhang, K., & Wang, J. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00775 · Cited by 30
The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months 6–12
Wall, M., Kupersmith, M. J., Thurtell, M. J., Moss, H. E., Moss, E.-A., & Auinger, P. (2017) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2017.01.004 · Cited by 30
Shah, K., Eghrari, A. O., Vanner, E. A., O’Brien, T. P., & Koo, E. H. (2021) · Cornea · doi:10.1097/ico.0000000000002762 · Cited by 31
Subhi, Y., Henningsen, G. Ø., Larsen, C. T., Sørensen, M. S., & Sørensen, T. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091227 · Cited by 31
Schippert, A. C., Jelin, E., Moe, M. C., Heiberg, T., & Grov, E. K. (2018) · Gerontology and Geriatric Medicine · doi:10.1177/2333721418801601 · Cited by 33
Sugar, E. A., Venugopal, V., Thorne, J. E., Frick, K. D., Holland, G. N., Wang, R. C., Almanzor, R. D., Jabs, D. A., & Holbrook, J. T. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.05.015 · Cited by 28
Patnaik, J. L., Lynch, A. M., Pecen, P. E., Jasso, M., Hanson, K., Mathias, M. T., Palestine, A. G., & Mandava, N. (2020) · Acta Ophthalmologica · doi:10.1111/aos.14731 · Cited by 28
Lachance, A., Godbout, M., Antaki, F., Hébert, M., Bourgault, S., Caissie, M., Tourville, É., Durand, A., & Dirani, A. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.4.6 · Cited by 28
A Low-Vision Rehabilitation Program for Patients With Mild Cognitive Deficits
Whitson, H. E., Whitaker, D., Potter, G. G., McConnell, E. S., Tripp, F., Sanders, L. L., Muir, K. W., Cohen, H. J., & Cousins, S. W. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.1700 · Cited by 34
Multimodal Evaluation of Visual Function in Geographic Atrophy versus Normal Eyes
Burguera-Giménez, N., García‐Lázaro, S., Gregori, E. E., Gallego‐Pinazo, R., Burguera-Giménez, N., Rodríguez‐Vallejo, M., & Jonna, G. (2020) · Clinical ophthalmology · doi:10.2147/opth.s246245 · Cited by 24
Sabour‐Pickett, S., Loughman, J., Nolan, J. M., Stack, J., Pesudovs, K., Meagher, K. A., & Beatty, S. (2013) · Journal of Ophthalmology · doi:10.1155/2013/268438 · Cited by 28
Nickels, S., Schuster, A. K.-G., Elflein, H. M., Wolfram, C., Schulz, A., Münzel, T. F., Beutel, M. E., Schmidtmann, I. M., Finger, R. P., & Pfeiffer, N. (2019) · Health and Quality of Life Outcomes · doi:10.1186/s12955-019-1158-1 · Cited by 26
Age-Related Macular Degeneration and Quality of Life in Latinos: The Los Angeles Latino Eye Study
Choudhury, F., Varma, R., Klein, R., Gauderman, W. J., Azen, S. P., McKean‐Cowdin, R., & for the Los Angeles Latino Eye Study Group (2016) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2016.0794 · Cited by 23
Petrillo, J., Balcer, L. J., Galetta, S. L., Chai, Y., Xu, L., & Cadavid, D. (2018) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000697 · Cited by 24
King, A. J., Fernie, G., Hudson, J., Kernohan, A., Azuara‐Blanco, A., Burr, J. M., Homer, T. M., Shabaninejad, H., Sparrow, J. M., Garway‐Heath, D. F., et al. (2021) · Health Technology Assessment · doi:10.3310/hta25720 · Cited by 26
Wyrwich, K. W., & Norman, G. R. (2022) · Quality of Life Research · doi:10.1007/s11136-022-03297-7 · Cited by 24
Advancements in the treatment of age-related macular degeneration: a comprehensive review
Papaioannou, C. (2024) · Postgraduate Medical Journal · doi:10.1093/postmj/qgae016 · Cited by 27
COMPARATIVE EFFECTIVENESS OF ANTI-VEGF AGENTS FOR DIABETIC MACULAR EDEMA
Ollendorf, D. A., Colby, J. A., & Pearson, S. D. (2013) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462313000500 · Cited by 24
Jelin, E., Wisløff, T. F., Moe, M. C., & Heiberg, T. (2019) · Health and Quality of Life Outcomes · doi:10.1186/s12955-019-1203-0 · Cited by 24
Clinical Trials in Noninfectious Uveitis
Kim, J. S.-Y., Knickelbein, J. E., Nussenblatt, R. B., & Sen, H. N. (2015) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000070 · Cited by 23
Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration
Steinle, N. C., Du, W., Gibson, A., & Saroj, N. (2020) · Ophthalmology Retina · doi:10.1016/j.oret.2020.07.003 · Cited by 23
Hamrah, P., Massaro‐Giordano, M., Schanzlin, D. J., Holland, E. J., Berdy, G. J., Goisis, G., Pasedis, G., & Mantelli, F. (2024) · Ophthalmology and Therapy · doi:10.1007/s40123-023-00866-y · Cited by 22
Subjective perception versus objective outcome after intravitreal ranibizumab for exudative AMD
Koch, K. R., Muether, P. S., Hermann, M. M., Hoerster, R., Kirchhof, B., & Fauser, S. (2011) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-011-1792-8 · Cited by 24
Brazier, J. E., Muston, D., Konwea, H., Power, G. S., Barzey, V., Lloyd, A., Sowade, O., Vitti, B., Gerlinger, C., & Roberts, J. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-21945 · Cited by 21
Jelin, E., Wisløff, T. F., Jørstad, Ø. K., Heiberg, T., & Moe, M. C. (2019) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2019-000353 · Cited by 22
Estimating Minimally Important Differences for Two Vision-Specific Quality of Life Measures
Gillespie, B. W., Musch, D. C., Niziol, L. M., & Janz, N. K. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13683 · Cited by 23
Rossouw, P., Guichard, M.-M., & Hatz, K. B. (2020) · Ophthalmic and Physiological Optics · doi:10.1111/opo.12736 · Cited by 23
Inoue, M., Arakawa, A., Yamane, S., & Kadonosono, K. (2014) · Clinical ophthalmology · doi:10.2147/opth.s68293 · Cited by 20
Mitchell, P., Massin, P., Bressler, S. B., Coon, C. D., Petrillo, J., Ferreira, A., & Bressler, N. M. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1081880 · Cited by 21
Self-citationCanamary, A. M., Monteiro, I. R., Mangeon, M. K., Regatieri, C. V., da Silva, L. M. P., Casaroli-Marano, R. P., & Muccioli, C. (2019) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2019.1612453 · Cited by 21
Suñer, I. J., Bressler, N. M., Varma, R., Dolan, C., Ward, J., & Turpcu, A. (2016) · Retina · doi:10.1097/iae.0000000000001316 · Cited by 21
Self-citationSugar, E. A., Burke, A. E., Venugopal, V., Thorne, J. E., & Holbrook, J. T. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2020.07.038 · Cited by 19
Zhu, M., Wijeyakumar, W., Syed, A., Joachim, N., Hong, T., Broadhead, G., Li, H., Luo, K., & Chang, A. (2016) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-016-3477-9 · Cited by 20
Current treatment strategies for symptomatic vitreous opacities
Ryan, E. H. (2021) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000752 · Cited by 16
Vélez, C. M., Ramírez, P. B., Cáceres, M. D. P. O., Lugo‐Agudelo, L. H., Posada, A. M., Hernández-Padilla, M. L., Valverde, E. A., & Suárez-Escudero, J. C. (2022) · Ophthalmic Epidemiology · doi:10.1080/09286586.2022.2093919 · Cited by 19
the Participating Investigators, Gomi, F., Migita, H., Sakaguchi, T., Okada, H., Sugawara, T., & Hikichi, Y. (2019) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-019-00687-2 · Cited by 18
Whitson, H. E., Ansah, D., Sanders, L. L., Whitaker, D., Potter, G. G., Cousins, S. W., Steffens, D. C., Landerman, L. R., Pieper, C. F., & Cohen, H. J. (2011) · Aging Clinical and Experimental Research · doi:10.1007/bf03325233 · Cited by 15
Künzel, S. H., Broadbent, E., Möller, P. T., Lindner, M., Goerdt, L., Czauderna, J., Schmitz-Valckenberg, S., Holz, F. G., Pfau, M., & Fleckenstein, M. (2024) · Ophthalmology Retina · doi:10.1016/j.oret.2024.01.025 · Cited by 14
Clark, W. L., Liu, M., Kitchens, J. W., Wang, P.-W., & Hašková, Z. (2019) · BMC Ophthalmology · doi:10.1186/s12886-018-1012-y · Cited by 14
Donati, S., Yang, C., Xu, X., Mura, M., Giocanti‐Auregan, A., Hoerauf, H., Allmeier, H., Machewitz, T., Johnson, K. T. M., Santoro, E. Y., et al. (2023) · Ophthalmology and Therapy · doi:10.1007/s40123-023-00829-3 · Cited by 13
Navarro, R. M., Machado, L. M., Maia, O., Wu, L., Farah, M. E., Magalhães, O., Arévalo, J. F., & Maia, M. (2015) · Journal of Ophthalmology · doi:10.1155/2015/156910 · Cited by 13
Corticosteroid implants for chronic non-infectious uveitis
Reddy, A. K., Liu, S., Brady, C. J., Sieving, P. C., & Palestine, A. G. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010469.pub3 · Cited by 13
Adrian, M. L., & Rung (2013) · Clinical ophthalmology · doi:10.2147/opth.s41585 · Cited by 13
Namba, K., Kaburaki, T., Tsuruga, H., Ogawa, Y., Iwashita, E., & Gotô, H. (2022) · Ophthalmology and Therapy · doi:10.1007/s40123-022-00493-z · Cited by 12
Giocanti‐Auregan, A., Donati, S., Hoerauf, H., Allmeier, H., Rittenhouse, K. D., Machewitz, T., Yang, C., & On behalf of the AURIGA Study Investigators (2023) · Ophthalmology and Therapy · doi:10.1007/s40123-023-00830-w · Cited by 12
Self-Reported Visual Quality of Life After Combat Ocular Trauma
McLaughlin, A., Colyer, M. H., Ryan, D. S., Sia, R. K., Weichel, E. D., Spiegelman, A. M., Eaddy, S. G., Mazzoli, R. A., & Bower, K. S. (2017) · Military Medicine · doi:10.7205/milmed-d-16-00139 · Cited by 12
Ramu, J., Chatziralli, I., Yang, Y. C., Menon, G., Bailey, C., Eckstein, M., Hykin, P. G., & Sivaprasad, S. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s132859 · Cited by 12
Kelly, N. K., Chattopadhyay, A., Rathinam, S. R., Gonzales, J. A., Thundikandy, R., Kanakath, A. V., Murugan, S., Vedhanayaki, R., Cugley, D. R., Lim, L. L., et al. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2021.02.024 · Cited by 12
Metadata
- Authors
- Sun~er, I. J., Kokame, G. T., Yu, E., Ward, J., Dolan, C., & Bressler, N. M.
- Affiliations
- From the Retina Associates of Florida, Tampa, Florida;
- University of Hawaiʻi at Mānoa (US)
- Genentech (US)
- Johns Hopkins University (US)
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2009-08-01
- Volume
- 50
- Issue
- 8
- Pages
- 3629
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2158029475
- Cited by
- 170
- References
- 32
- Citations by year
- 2026: 12 · 2025: 6 · 2024: 11 · 2023: 9 · 2022: 13 · 2021: 11 · 2020: 19 · 2019: 9 · 2018: 3 · 2017: 17 · 2016: 7 · 2015: 6 · 2014: 15 · 2013: 14 · 2012: 3
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Impairment Studies
- Keywords
- NEI VFQ-25, visual function questionnaire, neovascular age-related macular degeneration, visual acuity change, questionnaire responsiveness, ranibizumab, MARINA trial, ANCHOR trial
- MeSH terms
- Ranibizumab, Aged, Aged, 80 and over, Antibodies, Monoclonal, Double-Blind Method, Female, Humans, Injections, Macular Degeneration, Male, Middle Aged, National Institutes of Health (U.S.), Surveys and Questionnaires, Sensitivity and Specificity, United States, Visual Acuity, Vitreous Body, Sickness Impact Profile, Choroidal Neovascularization, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.